{"url_path":"/fda/drug/recalls/D-0728-2026","section_key":"summary","section_title":"DRUG Recall: Fresenius Kabi USA, LLC — Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile,  Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial:  63323-485-01","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-07-16","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0728-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Fresenius Kabi USA, LLC"},"word_count":89,"has_tables":false,"body_markdown":null}